ℹ️
🇬🇧
Search
Search for publications relevant for "CONTROLLED PHASE-3 TRIAL"
CONTROLLED PHASE-3 TRIAL
Publication
Class
Person
Publication
Programmes
publication
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
2017 |
First Faculty of Medicine
publication
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
2017 |
First Faculty of Medicine
publication
Alemtuzumab long-term immunologic effect Treg suppressor function increases up to 24 months
2016 |
First Faculty of Medicine
publication
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
2017 |
First Faculty of Medicine
publication
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS
2016 |
First Faculty of Medicine